A Quantitative Systems Pharmacology Model of the Pathophysiology and Treatment of COVID-19 Predicts Optimal Timing of Pharmacological Interventions
Rohit Rao, Cynthia J. Musante, Richard Allen
doi: https://doi.org/10.1101/2021.12.07.21267277
Rohit Rao
Early Clinical Development, Pfizer Worldwide Research, Development and Medical, Cambridge, MA, USA
Cynthia J. Musante
Early Clinical Development, Pfizer Worldwide Research, Development and Medical, Cambridge, MA, USA
Richard Allen
Early Clinical Development, Pfizer Worldwide Research, Development and Medical, Cambridge, MA, USA
Posted December 08, 2021.
A Quantitative Systems Pharmacology Model of the Pathophysiology and Treatment of COVID-19 Predicts Optimal Timing of Pharmacological Interventions
Rohit Rao, Cynthia J. Musante, Richard Allen
medRxiv 2021.12.07.21267277; doi: https://doi.org/10.1101/2021.12.07.21267277
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (632)
- Anesthesia (168)
- Cardiovascular Medicine (2400)
- Dermatology (207)
- Emergency Medicine (381)
- Epidemiology (11799)
- Forensic Medicine (10)
- Gastroenterology (705)
- Genetic and Genomic Medicine (3769)
- Geriatric Medicine (350)
- Health Economics (637)
- Health Informatics (2409)
- Health Policy (940)
- Hematology (342)
- HIV/AIDS (787)
- Medical Education (369)
- Medical Ethics (105)
- Nephrology (401)
- Neurology (3524)
- Nursing (199)
- Nutrition (529)
- Oncology (1835)
- Ophthalmology (539)
- Orthopedics (221)
- Otolaryngology (287)
- Pain Medicine (234)
- Palliative Medicine (66)
- Pathology (447)
- Pediatrics (1038)
- Primary Care Research (424)
- Public and Global Health (6184)
- Radiology and Imaging (1291)
- Respiratory Medicine (832)
- Rheumatology (380)
- Sports Medicine (324)
- Surgery (406)
- Toxicology (50)
- Transplantation (172)
- Urology (147)